Xenon Pharmaceuticals IncNASDAQ:XENE
- LAST PRICE42.4900
- TODAY'S CHANGE (%)1.8400 (4.5264%)
- Bid / Lots41.5100/ 1
- Ask / Lots43.6700/ 1
- Open / Previous Close41.1600 / 40.6500
- Day Range
- 52 Week Range
- Volume368,985
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | XENE |
|---|---|---|
| 09:32 ET | 3503 | 41.16 |
| 09:34 ET | 700 | 41.53 |
| 09:38 ET | 260 | 41.48 |
| 09:39 ET | 100 | 41.505 |
| 09:43 ET | 100 | 41.92 |
| 09:45 ET | 100 | 42.135 |
| 09:56 ET | 168 | 41.92 |
| 10:01 ET | 200 | 42.12 |
| 10:15 ET | 100 | 41.97 |
| 10:19 ET | 100 | 41.825 |
| 10:24 ET | 500 | 42.05 |
| 10:26 ET | 905 | 42.075 |
| 10:32 ET | 465 | 42.0021 |
| 10:39 ET | 100 | 42.035 |
| 10:42 ET | 200 | 42.07 |
| 10:44 ET | 746 | 42.235 |
| 10:48 ET | 100 | 42.28 |
| 10:50 ET | 600 | 42.27 |
| 10:51 ET | 500 | 42.065 |
| 10:55 ET | 300 | 42.05 |
| 10:57 ET | 300 | 41.94 |
| 11:02 ET | 197 | 41.785 |
| 11:04 ET | 100 | 41.78 |
| 11:09 ET | 100 | 41.73 |
| 11:11 ET | 500 | 41.7 |
| 11:13 ET | 200 | 41.545 |
| 11:15 ET | 200 | 41.45 |
| 11:20 ET | 400 | 41.515 |
| 11:22 ET | 200 | 41.505 |
| 11:24 ET | 300 | 41.47 |
| 11:26 ET | 100 | 41.515 |
| 11:27 ET | 200 | 41.44 |
| 11:29 ET | 100 | 41.425 |
| 11:31 ET | 200 | 41.37 |
| 11:33 ET | 600 | 41.4 |
| 11:36 ET | 3808 | 41.4 |
| 11:38 ET | 62744 | 41.6 |
| 11:42 ET | 200 | 41.605 |
| 11:44 ET | 1228 | 41.61 |
| 11:49 ET | 400 | 41.44 |
| 11:54 ET | 100 | 41.47 |
| 11:56 ET | 500 | 41.48 |
| 11:58 ET | 900 | 41.48 |
| 12:00 ET | 4896 | 41.71 |
| 12:05 ET | 919 | 41.9 |
| 12:07 ET | 400 | 41.98 |
| 12:09 ET | 300 | 41.98 |
| 12:12 ET | 300 | 42.08 |
| 12:14 ET | 400 | 41.9 |
| 12:18 ET | 390 | 42 |
| 12:20 ET | 100 | 42.09 |
| 12:21 ET | 200 | 42.04 |
| 12:23 ET | 100 | 42.07 |
| 12:25 ET | 200 | 42.14 |
| 12:30 ET | 611 | 42.17 |
| 12:34 ET | 300 | 42.315 |
| 12:36 ET | 218 | 42.39 |
| 12:38 ET | 1100 | 42.36 |
| 12:39 ET | 1000 | 42.425 |
| 12:41 ET | 100 | 42.405 |
| 12:43 ET | 200 | 42.46 |
| 12:45 ET | 200 | 42.39 |
| 12:48 ET | 200 | 42.425 |
| 12:50 ET | 1136 | 42.395 |
| 12:54 ET | 700 | 42.39 |
| 12:56 ET | 100 | 42.43 |
| 12:59 ET | 700 | 42.38 |
| 01:01 ET | 444 | 42.345 |
| 01:03 ET | 300 | 42.44 |
| 01:14 ET | 100 | 42.36 |
| 01:15 ET | 100 | 42.37 |
| 01:19 ET | 1117 | 42.41 |
| 01:26 ET | 100 | 42.49 |
| 01:28 ET | 2796 | 42.49 |
| 01:30 ET | 236 | 42.54 |
| 01:35 ET | 100 | 42.51 |
| 01:39 ET | 440 | 42.49 |
| 01:42 ET | 200 | 42.49 |
| 01:46 ET | 100 | 42.51 |
| 01:50 ET | 1100 | 42.55 |
| 01:51 ET | 1158 | 42.495 |
| 01:53 ET | 1900 | 42.35 |
| 01:57 ET | 100 | 42.325 |
| 02:00 ET | 200 | 42.27 |
| 02:02 ET | 200 | 42.23 |
| 02:04 ET | 300 | 42.2525 |
| 02:08 ET | 2544 | 42.47 |
| 02:09 ET | 100 | 42.41 |
| 02:11 ET | 100 | 42.395 |
| 02:13 ET | 300 | 42.435 |
| 02:15 ET | 200 | 42.49 |
| 02:18 ET | 200 | 42.48 |
| 02:20 ET | 200 | 42.56 |
| 02:24 ET | 1263 | 42.665 |
| 02:26 ET | 200 | 42.64 |
| 02:27 ET | 300 | 42.71 |
| 02:29 ET | 900 | 42.825 |
| 02:31 ET | 600 | 42.64 |
| 02:33 ET | 700 | 42.61 |
| 02:36 ET | 800 | 42.77 |
| 02:40 ET | 200 | 42.73 |
| 02:42 ET | 400 | 42.82 |
| 02:44 ET | 800 | 42.905 |
| 02:47 ET | 723 | 42.92 |
| 02:49 ET | 500 | 42.945 |
| 02:51 ET | 300 | 42.915 |
| 02:54 ET | 817 | 43 |
| 02:56 ET | 1227 | 43.08 |
| 02:58 ET | 600 | 43.14 |
| 03:00 ET | 1989 | 43.4 |
| 03:02 ET | 800 | 43.41 |
| 03:03 ET | 2603 | 43.275 |
| 03:05 ET | 800 | 43.32 |
| 03:07 ET | 4212 | 43.55 |
| 03:09 ET | 2036 | 43.55 |
| 03:12 ET | 600 | 43.52 |
| 03:14 ET | 600 | 43.51 |
| 03:16 ET | 1008 | 43.37 |
| 03:18 ET | 484 | 43.365 |
| 03:20 ET | 1772 | 43.36 |
| 03:21 ET | 700 | 43.325 |
| 03:23 ET | 1112 | 43.27 |
| 03:25 ET | 800 | 43.46 |
| 03:27 ET | 800 | 43.49 |
| 03:30 ET | 712 | 43.41 |
| 03:32 ET | 2114 | 43.35 |
| 03:34 ET | 1435 | 43.26 |
| 03:36 ET | 1926 | 43.1936 |
| 03:38 ET | 797 | 43.215 |
| 03:39 ET | 900 | 43.115 |
| 03:41 ET | 3225 | 43.045 |
| 03:43 ET | 1596 | 42.95 |
| 03:45 ET | 1397 | 42.935 |
| 03:48 ET | 1819 | 42.92 |
| 03:50 ET | 3181 | 42.915 |
| 03:52 ET | 11629 | 42.6 |
| 03:54 ET | 5041 | 42.665 |
| 03:56 ET | 5696 | 42.79 |
| 03:57 ET | 8141 | 42.595 |
| 03:59 ET | 10017 | 42.49 |
Apr 16, 2024
Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting, from 8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
8:30AM ET on Tuesday Apr 16, 2024 by Dow Jones
Apr 12, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $62.00/Share by Needham, from 7:13AM ET on Friday Apr 12, 2024 by Dow Jones
7:13AM ET on Friday Apr 12, 2024 by Dow Jones
Apr 10, 2024
DJ Xenon Pharmaceuticals Price Target Maintained With a $65.00/Share by Cantor Fitzgerald, from 9:57AM ET on Wednesday Apr 10, 2024 by Dow Jones
9:57AM ET on Wednesday Apr 10, 2024 by Dow JonesXenon Pharmaceuticals to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference, from 8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
8:30AM ET on Wednesday Apr 10, 2024 by Dow Jones
Apr 4, 2024
Xenon Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference, from 4:01PM ET on Thursday Apr 04, 2024 by Dow Jones
4:01PM ET on Thursday Apr 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Xenon Pharmaceuticals Inc | 3.1B | -15.6x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
IDEAYA Biosciences Inc | 3.0B | -21.0x | --- |
Janux Therapeutics Inc | 2.9B | -43.4x | --- |
Apogee Therapeutics Inc | 2.8B | -29.3x | --- |
Iovance Biotherapeutics Inc | 3.3B | -6.6x | --- |
Company Information
Xenon Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company focused on developing therapeutics to improve the lives of patients with neurological disorders, with a focus on epilepsy. The Company’s product pipeline includes XEN1101 (Focal Onset Seizures), XEN1101 (Primary Generalized Tonic-Clonic Seizures), XEN1101 (Major Depressive Disorder) and NBI-921352 (NEUROCRINE). It is developing XEN1101, a differentiated Kv7 potassium channel opener, for the treatment of epilepsy, MDD and potentially other neurological disorders. Its XEN1101 Phase III epilepsy program includes two identical Phase III clinical trials, called X-TOLE2 and X-TOLE3, that are designed closely after the Phase IIb X-TOLE clinical trial. Its Phase III X-ACKT clinical trial is intended to support potential regulatory submissions in an additional epilepsy indication of primary generalized tonic-clonic seizures (PGTCS).
Contact Information
- Headquarters
- 3650 Gilmore WayVANCOUVER, BC, Canada V5G 4W8
- Phone
- 604-484-3300
- Fax
- 604-484-3450
Executives
- Chairman of the Board
- Simon Pimstone
- President, Chief Executive Officer, Director
- Ian Mortimer
- Chief Financial Officer
- Sherry Aulin
- Executive Vice President - Drug Discovery
- James Empfield
- Executive Vice President - Strategy and Innovation
- Robin Sherrington
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.1B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 75.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.19 |
EPS | $-2.73 |
Book Value | $12.31 |
P/E Ratio | -15.6x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
